LONDON – People carrying one copy of a rare mutant gene are at 65 percent lower risk of developing type 2 diabetes, a genomewide association study has found. The work suggests that it may be possible one day to develop therapies that target the protein encoded by the gene in question, which is known to play a role in insulin secretion.